The Institute of Biomedicine and Translational Medicine at the University of Tartu is a research and education institute in biomedical sciences. The research areas include basic and translational medicine.The mission is to create an internationally high standard research and education institute operating in the field of biomedicine.
The specific research projects are given at homepages of each work group:
Read more about of the Department of Pharmacology.
Project: The effect of DNA methyltransferase-inhibitor treatment on aberrant DNA methylation in human leukocytes: A novel pharmacological strategy for treatment of psychostimulant-induced drug addiction (Estonian Research Council, GMVBS22063PR)
Period: 01.01.2022−31.12.2026
Contact: Professor Anti Kalda
E-mail: [email protected]
Project: Targeting the endoplasmic reticulum-mitochondrial interface as a therapeutic strategy for neurodegenerative diseases (Estonian Research Council, GMVBS24041PR)
Period: 01.01.2024−31.12.2028
Contact: Professor Allen Kaasik
E-mail: [email protected]
Project: Imaging and enhancing synaptic ATP in neurodegenerative disease models (Silicon Valley Community Foundation (Chan Zuckerberg Initiative DAF), MMVBS24595)
Period: 01.12.2024 30.11.2025
Contact: Professor Allen Kaasik
E-mail: [email protected]
Project: Estonian BioImaging (Estonian Research Council, SMVBS25367)
Period: 01.01.2025-31.12.2029
Contact: Professor Allen Kaasik
E-mail: [email protected]
Project: Redox active peptide drug candidate (The State Shared Service Center, SMVBS25451YT)
Periods: 01.09.2025-31.08.2026
Contact: Professor Allen Kaasik
E-mail: [email protected]
Read more about of the Department of Physiology.
Project: Metabolic and genetic signatures of the dynamics of first-episode psychosis: associations with adverse effects of antipsychotic treatment (Estonian Research Council, GMVBS25033PR)
Period: 01.01.2025−31.12.2029
Contact: Professor Eero Vasar
E-mail: [email protected]
Project: HIF1B as a Novel Hypothermia Response Factor with Therapeutic Benefits (Estonian Research Council, GMVBS24069PS)
Period: 01.01.2024-31.12.2028
Contact: Research Fellow Kattri-Liis Eskla
E-mail: [email protected]
Read more about the research of the Molecular Pathology Research Group.
Project: Type I interferons and their autoantibodies in autoimmunity and COVID-19 (Estonian Research Council, GMVBS21081PR)
Period: 01.01.2021−31.12.2025
Contact: Professor Kai Kisand
E-mail: [email protected]
Project: Molecular mechanisms underlying impaired antiviral cytotoxic T cell responses in old age (Estonian Research Council, SMVBS21533)
Period: 01.12.2021−30.11.2026
Contact: Research Fellow Maarja Laos
E-mail: [email protected]
Project: The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards personalised medicine (European Commission, MMVBS22163R)
Period: 01.06.2022−31.05.2026
Contact: Professor Kai Kisand
E-mail: [email protected]
Project: Age-Related Changes in T Cells (Estonian Research Council, GMVBS24044PR)
Period: 01.01.2024−31.12.2028
Contact: Professor Pärt Peterson
E-mail: [email protected]
Project: Preventing non-communicable diseases caused by the post-acute phase of cOvid-19 INfecTion (European Commission Horizon2020, GMVBS24044PR)
Period: 01.01.2024−31.12.2027
Contact: Professor Pärt Peterson
E-mail: [email protected]
Project: Enterovirus-linked type1 diabetes exposed - mechanisms and preventions (European Commission Horizon2020, MMVBS24075R)
Period: 01.01.2024−31.12.2027
Contact: Professor Pärt Peterson
E-mail: [email protected]
Project: Building Excellence in Systems Immunology and Healthy Aging Research (European Commission, MMVBS24271R)
Period: 01.09.2024−31.08.2027
Contact: Professor Kai Kisand
E-mail: [email protected]
Read more about the research of the Laboratory of Precision and Nanomedicine.
Project: Precision targeting of infiltrative glioblastoma (Estonian Research Council, GMVBS23048PR)
Period: 01.01.2023−31.12.2027
Contact: Professor Tambet Teesalu
E-mail: [email protected]
Project: Macrophage-targeting Nanoplatforms as Immunotherapy against Pulmonary Infections (USA, MMVBS24156)
Period: 11.01.2024−30.11.2025
Contact: Professor Tambet Teesalu
E-mail: [email protected]
Project: Glioblastoma targeting using peptide-functionalized nanoparticles loaded with nucleic acids (Estonian Research Council. SMVBS24514YT)
Period: 01.12.2024-30.11.2026
Contact: Professor Tambet Teesalu
E-mail: [email protected]
Project: Programmable Bionanomaterials with Protein-Controlled Behavior (European Commission MMVBS25006R)
Period: 01.01.2025-31.12.2028
Contact: Professor Tambet Teesalu
E-mail: [email protected]
Read more about the research of the RNA Biology Research Group.
Project: Adjustment of tissue-specific immune responses in chronic inflammatory diseases by miRNAs (Estonian Research Council, GMVBS21063PR)
Period: 01.01.2021−31.12.2025
Contact: Professor Ana Rebane
E-mail: [email protected]
Read more about the research of the Chair of Human Genetics.
Project: Mono- and digenic causes of male infertility in the exome sequencing era: novel genes, digenic inheritance, pleiotropic effects and clinical implications (Estonian Research Council, GMVBS21064PR)
Period: 01.01.2021–31.12.2025
Contact: Professor Maris Laan
E-mail: [email protected]
Read more about the research of the Department of Immunology.
Project: Immune mechanisms in adulthood diabetes (Estonian Research Council, GMVBS0377PR)
Period: 01.01.2020–31.12.2025
Contact: Professor Raivo Uibo
E-mail: [email protected]
Read more about the research of the Department of Anatomy.
Project: Human histology (Institute of the Estonian Language, DMVBS21510)
Period: 16.09.2021–31.08.2026
Contact: Associate Professor Marina Aunapuu
E-mail: [email protected]
Read more about the research of the Department of Microbiology.
Project: Delivering a Unified Research Alliance of Biomedical and public health Laboratories against Epidemics (European Commission, MMVBS23022)
Period: 01.02.2023–31.01.2027
Contact: Professor Irja Lutsar
E-mail: [email protected]
Project: Boosting the One Health Research Excellence and Management Capacity of the Estonian University of Life Sciences (European Commission, MMVBS23128R)
Period: 01.01-2023–31.12.2025
Contact: Professor Irja Lutsar
E-mail: [email protected]
Project: SARS-coV2 variants Evaluation in pRegnancy and paeDIatrics cohorts (European Commission, MMVBS23269R)
Period: 01.05.2023–31.10.2025
Contact: Professor Irja Lutsar
E-mail: [email protected]
Projekti nimi: Seroepidemiologic Study (Health Board, LMVBS24547)
Period: 01.11.2024-31.03.2027
Contact: Lekturer Kai Truusalu
E-post: [email protected]
Projekti nimi: Infrastructure of Food Innovation Technologies (Estonian Research Council, SMVBS25308)
Period: 01.01.2025-31.12.2029
Contact: Professor Reet Mändar
E-mail: [email protected]
Projekti nimi: The Role of Virome in Development of Microbiota and Sepsis in Preterm Neonates (Estonian Research Council, GMVBS25098PR)
Period: 01.01.2025-31.12.2029
Contact: Associated Professor Kristi Huik
E-mail: [email protected]
Project: Reducing Gastrointestinal Side Effects of GLP-1 Analogues with a New Combination Therapy (The State Shared Service Center, SMVBS25464YT)
Period: 01.09.2025-31.08.2026
Contact: Professor Mario Plaas
E-mail: [email protected]